Vaccinex receives Nasdaq delisting notice; trading suspended Dec 18, 2024

VACCINEX, INC.

Nasdaq Hearings Panel determined to delist VCNX for failing to maintain $2.5M minimum stockholders' equity.
Trading suspension effective at open of trading on Wednesday, December 18, 2024.
Company expects common stock to be quoted on OTC Markets Group under symbol VCNX.
Press release issued December 17, 2024 announcing the delisting determination.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.